Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.5063
+0.0214 (4.41%)
At close: Sep 23, 2026, 4:00 PM EDT
0.5100
+0.0037 (0.73%)
After-hours: Sep 23, 2026, 7:42 PM EDT
Bone Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 4.03 | 4.53 | 5.33 | 6.05 | 6.64 | 2.75 | 3.33 | 3.57 | 2.33 | 3.23 | 3.03 | 4.45 | 7.01 | 6.19 | 7.54 | 5.06 | 5.45 | 5.81 | 6.68 | 0 |
Cash & Short-Term Investments | 4.03 | 4.53 | 5.33 | 6.05 | 6.64 | 2.75 | 3.33 | 3.57 | 2.33 | 3.23 | 3.03 | 4.45 | 7.01 | 6.19 | 7.54 | 5.06 | 5.45 | 5.81 | 6.68 | 0 |
Cash Growth (YoY) | -39.28% | 64.94% | 60.42% | 69.61% | 184.75% | -14.90% | 9.87% | -19.90% | -66.72% | -47.84% | -59.85% | -11.99% | 28.48% | 6.43% | 12.93% | 149847.93% | 122804.96% | 8070.57% | - | 37.10% |
Other Receivables | 0.01 | 0.01 | 0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Receivables | 0.01 | 0.01 | 0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Prepaid Expenses | 0.14 | 0.18 | 0.24 | 0.08 | 0.15 | 0.21 | 0.28 | 0.11 | 0.21 | 0.28 | 0.38 | 0.52 | 0.62 | 0.6 | 0.38 | 0.14 | 0.2 | 0.28 | - | - |
Other Current Assets | 0.26 | 0.26 | 0.21 | 0.22 | 0.21 | 0.21 | 0.26 | 0.39 | 0.65 | 0.33 | 0.33 | - | - | - | 0.58 | - | - | - | - | 0.05 |
Total Current Assets | 4.44 | 4.98 | 5.8 | 6.35 | 7 | 3.16 | 3.86 | 4.07 | 3.19 | 3.84 | 3.74 | 4.98 | 7.62 | 6.78 | 8.5 | 5.2 | 5.66 | 6.09 | 6.68 | 0.05 |
Total Assets | 4.44 | 4.98 | 5.8 | 6.35 | 7 | 3.16 | 3.86 | 4.07 | 3.19 | 3.84 | 3.74 | 4.98 | 7.62 | 6.78 | 8.5 | 5.2 | 5.66 | 6.09 | 6.68 | 0.05 |
Liabilities
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Accounts Payable | 0.51 | 0.31 | 0.42 | 0.33 | 0.4 | 0.25 | 0.37 | 0.19 | 0.23 | 0.15 | 0.36 | 1.1 | 1.69 | 2.28 | 0.1 | 0.8 | 0.07 | 0.05 | 0.1 | 0.07 |
Accrued Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.34 |
Short-Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.77 |
Current Portion of Long-Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.05 | 0.02 | 0.47 | 0.08 | 0.24 | 1.73 | 2.44 | - | - | - | - | - |
Total Current Liabilities | 0.51 | 0.31 | 0.42 | 0.33 | 0.41 | 0.25 | 0.38 | 0.27 | 0.28 | 0.16 | 0.83 | 1.18 | 1.93 | 4.01 | 2.55 | 0.8 | 0.07 | 0.05 | 0.1 | 15.18 |
Total Liabilities | 0.51 | 0.31 | 0.42 | 0.33 | 0.41 | 0.25 | 0.38 | 0.27 | 0.28 | 0.16 | 0.83 | 1.18 | 1.93 | 4.01 | 2.55 | 0.8 | 0.07 | 0.05 | 0.1 | 15.18 |
Shareholders' Equity
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 93.59 | 93.56 | 93.51 | 93.46 | 93.37 | 88.95 | 88.5 | 87.29 | 85.47 | 85.45 | 83.81 | 83.15 | 83.13 | 78.43 | 77.91 | 77.24 | 77.21 | 77.19 | 77.04 | 55.16 |
Retained Earnings | -89.67 | -88.9 | -88.13 | -87.45 | -86.78 | -86.04 | -85.02 | -83.5 | -82.56 | -81.77 | -80.91 | -79.36 | -77.44 | -75.67 | -71.96 | -72.85 | -71.63 | -71.17 | -70.48 | -70.3 |
Shareholders' Equity | 3.92 | 4.67 | 5.38 | 6.02 | 6.6 | 2.91 | 3.48 | 3.79 | 2.91 | 3.67 | 2.91 | 3.79 | 5.69 | 2.77 | 5.95 | 4.4 | 5.59 | 6.04 | 6.58 | -15.13 |
Total Liabilities & Equity | 4.44 | 4.98 | 5.8 | 6.35 | 7 | 3.16 | 3.86 | 4.07 | 3.19 | 3.84 | 3.74 | 4.98 | 7.62 | 6.78 | 8.5 | 5.2 | 5.66 | 6.09 | 6.68 | 0.05 |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.77 |
Net Cash (Debt) | 4.03 | 4.53 | 5.33 | 6.05 | 6.64 | 2.75 | 3.33 | 3.57 | 2.33 | 3.23 | 3.03 | 4.45 | 7.01 | 6.19 | 7.54 | 5.06 | 5.45 | 5.81 | 6.68 | -12.76 |
Net Cash Growth (YoY) | -39.28% | 64.94% | 60.42% | 69.61% | 184.75% | -14.90% | 9.87% | -19.90% | -66.72% | -47.84% | -59.85% | -11.99% | 28.48% | 6.43% | 12.93% | - | - | - | - | - |
Net Cash Per Share | 2.24 | 3.04 | 4.54 | 7.31 | 14.79 | 7.67 | 13.14 | 21.14 | 24.41 | 47.05 | 69.01 | 163.24 | 242.19 | - | - | - | - | - | - | - |
Filing Date Shares Outstanding | 2.76 | 1.8 | 1.8 | 1.8 | 1.8 | 0.55 | 0.55 | 0.41 | 0.3 | 0.18 | 0.09 | 0.09 | 0.07 | 0.01 | 0.01 | 0.01 | - | - | - | - |
Total Common Shares Outstanding | 1.81 | 1.8 | 1.8 | 1.8 | 1.69 | 0.55 | 0.49 | 0.35 | 0.22 | 0.17 | 0.09 | 0.07 | 0.07 | 0.01 | 0.01 | - | - | - | - | - |
Working Capital | 3.92 | 4.67 | 5.38 | 6.02 | 6.6 | 2.91 | 3.48 | 3.79 | 2.91 | 3.67 | 2.91 | 3.79 | 5.69 | 2.77 | 5.95 | 4.4 | 5.59 | 6.04 | 6.58 | -15.13 |
Book Value Per Share | 2.17 | 2.60 | 3.00 | 3.35 | 3.91 | 5.34 | 7.08 | 10.85 | 13.27 | 21.69 | 32.64 | 58.08 | 87.18 | 239.02 | 559.69 | - | - | - | - | - |
Tangible Book Value | 3.92 | 4.67 | 5.38 | 6.02 | 6.6 | 2.91 | 3.48 | 3.79 | 2.91 | 3.67 | 2.91 | 3.79 | 5.69 | 2.77 | 5.95 | 4.4 | 5.59 | 6.04 | 6.58 | -15.13 |
Tangible Book Value Per Share | 2.17 | 2.60 | 3.00 | 3.35 | 3.91 | 5.34 | 7.08 | 10.85 | 13.27 | 21.69 | 32.64 | 58.08 | 87.18 | 239.02 | 559.69 | - | - | - | - | - |